GSK in the PHARMECO Project
We’re proud to celebrate the impactful role of the SERVIER (SERV) in the PHARMECO initiative—an ambitious Horizon Europe project advancing Safe and Sustainable by Design (SSbD) practices in pharmaceutical manufacturing.
SERV brings deep scientific expertise and innovation to the table, particularly in:
🧠 Expert guidance in (bio)chemical process development
We’re proud to celebrate the impactful role of the GSK in the PHARMECO initiative—an ambitious Horizon Europe project advancing Safe and Sustainable by Design (SSbD) practices in pharmaceutical manufacturing.
GSK, as industry partner, brings deep scientific expertise and innovation to the table, particularly in:
🌱Assess sustainability in pharma route design.
🧩Adapt SSbD framework for pharma sector
Its contribution is central to Work Package 7, which focuses on the sustainability evaluation of innovative (bio)manufacturing and decontamination technologies and pharmaceuticals, from a cradle-to-gate and eventually an end-to-end perspective via integrated assessment by tailoring the SSbD framework to pharma.
👏 A huge thank you to the GSK teams for their dedication to building a more sustainable pharmaceutical future!
